Liposomal amphotericin B [clinicaltrials_resource:7e5aca01920c37966c4c377e177a6fd8]
A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis [clinicaltrials:NCT00000639]Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis [clinicaltrials:NCT00000708]Dexamethasone in Cryptococcal Meningitis [clinicaltrials:NCT00000776]Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS [clinicaltrials:NCT00001017]A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole [clinicaltrials:NCT00001065]Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis [clinicaltrials:NCT00001646]Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome [clinicaltrials:NCT00002019]Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients [clinicaltrials:NCT00002041]A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis [clinicaltrials:NCT00002068]Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome [clinicaltrials:NCT00002074]Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis [clinicaltrials:NCT00002075]A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis [clinicaltrials:NCT00002159]A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections [clinicaltrials:NCT00002277]A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis [clinicaltrials:NCT00002305]A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B [clinicaltrials:NCT00002306]The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis [clinicaltrials:NCT00002316]Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer [clinicaltrials:NCT00002742]Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis [clinicaltrials:NCT00003031]Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With Invasive Fungal Infection [clinicaltrials:NCT00003315]Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients [clinicaltrials:NCT00003938]Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment [clinicaltrials:NCT00008359]Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis [clinicaltrials:NCT00012467]clinicaltrials:NCT00047827MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037) [clinicaltrials:NCT00076869]MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044) [clinicaltrials:NCT00082537]clinicaltrials:NCT00106288clinicaltrials:NCT00145249A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation [clinicaltrials:NCT00148148]Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment [clinicaltrials:NCT00158730]Ambisome in Liver Transplant Patients [clinicaltrials:NCT00161356]A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood. [clinicaltrials:NCT00163111]Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®) [clinicaltrials:NCT00177684]Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study [clinicaltrials:NCT00177710]Abelcet Radiotagging Protocol: Inhaled Lipid Complex Abelcet® in Lung Transplant Recipients [clinicaltrials:NCT00235651]Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis [clinicaltrials:NCT00263315]Amphotericin B Treatment in Visceral Leishmaniasis [clinicaltrials:NCT00310505]PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell Transplantation [clinicaltrials:NCT00326157]COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis [clinicaltrials:NCT00334412]PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute Leukaemia [clinicaltrials:NCT00362544]Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar [clinicaltrials:NCT00371995]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Liposomal amphotericin B [clinicaltrials_resource:7e5aca01920c37966c4c377e177a6fd8]
Bio2RDF identifier
7e5aca01920c37966c4c377e177a6fd8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7e5aca01920c37966c4c377e177a6fd8
identifier
clinicaltrials_resource:7e5aca01920c37966c4c377e177a6fd8
title
Liposomal amphotericin B
@en
type
label
Liposomal amphotericin B [clinicaltrials_resource:7e5aca01920c37966c4c377e177a6fd8]
@en